ELIQUIS

Swiss trademark · 600498 · Combined mark · Deleted

Register entry

Registration number
600498
Application number
52274/2010
Status
Deleted
Type
Combined mark
As registered
ELIQUIS ((fig.))
Filed
Mar 8, 2010
Registered
May 18, 2010
Published
May 18, 2010
Deleted
Oct 2, 2020
Reason
Not renewed
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für die Prävention und Behandlung von kardiovaskulären Störungen, ausgenommen diagnostische Produkte für den medizinischen, veterinärmedizinischen und wissenschaftlichen Gebrauch.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 2, 2020

    Deleted, not renewed

    Published in Swissreg on 02.10.2020

  2. Apr 29, 2011

    Transferred

    Owner
    Pfizer Products Inc., Eastern Point Road, Groton, CT 06340, USA → Bristol-Myers Squibb Company, 345 Park Avenue, New York, NY 10154, USA

    Published in Swissreg on 29.04.2011

  3. May 18, 2010

    Registered

    Published in Swissreg on 18.05.2010

Parties

Holder

Bristol-Myers Squibb Company

345 Park Avenue, New York, NY 10154, US

Agent

E. Blum & Co. AG

E. Blum & Co. AG Patent- und Markenanwälte VSP

Vorderberg 11, 8044 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.